NLS Pharmaceutics Ltd (NLSP)
3.365
+0.08
(+2.28%)
USD |
NASDAQ |
Nov 21, 16:00
3.17
-0.20
(-5.79%)
After-Hours: 20:00
NLS Pharmaceutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 81.61% |
| Addex Therapeutics Ltd | -- |
| Molecular Partners AG | -- |
| MoonLake Immunotherapeutics | -- |